Back to GetFilings.com



Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-Q
 
(Mark One)
 
 
x
 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2002.
 
OR
 
 
¨
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM                      TO                      .
 
Commission file number: 1-10989
 
Ventas, Inc.
(Exact name of registrant as specified in its charter)
 
Delaware
 
61-1055020
(State or other jurisdiction)
 
(I.R.S. Employer Identification No.)
 
4360 Brownsboro Road, Suite 115
Louisville, Kentucky
(Address of principal executive offices)
 
40207-1642
(Zip Code)
 
(502) 357-9000
(Registrant’s telephone number, including area code)
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x        No  ¨
 
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
 
Class of Common Stock:
 
Outstanding at October 25, 2002:
Common Stock, $.25 par value
 
69,664,028 Shares


Table of Contents
VENTAS, INC.
 
FORM 10-Q
 
INDEX
 
         
Page

  
3
     
3
       
3
       
4
       
5
       
6
       
7
     
30
     
47
     
48
  
49
     
49
     
49

2


Table of Contents
PART I—FINANCIAL INFORMATION
 
ITEM 1. FINANCIAL STATEMENTS
 
VENTAS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
 
    
September 30,
2002
(Unaudited)

    
December 31,
2001
(Audited)

 
Assets
             
Real estate investments:
                 
Land
  
$
116,625
 
  
$
119,771
 
Building and improvements
  
 
1,051,781
 
  
 
1,056,067
 
    


  


    
 
1,168,406
 
  
 
1,175,838
 
Accumulated depreciation
  
 
(398,425
)
  
 
(369,502
)
    


  


Total real estate investments
  
 
769,981
 
  
 
806,336
 
Cash and cash equivalents
  
 
4,121
 
  
 
18,596
 
Restricted cash
  
 
19,656
 
  
 
20,773
 
Deferred financing costs, net
  
 
19,678
 
  
 
14,153
 
Investment in Kindred Healthcare, Inc. common stock
  
 
34,098
 
  
 
55,118
 
Kindred Healthcare, Inc. common stock reserved for distribution
  
 
—  
 
  
 
17,086
 
Notes receivable from employees
  
 
4,186
 
  
 
3,635
 
Other
  
 
5,523
 
  
 
6,162
 
    


  


Total assets
  
$
857,243
 
  
$
941,859
 
    


  


Liabilities and stockholders’ equity
             
Liabilities:
                 
Notes payable and other debt
  
$
785,924
 
  
$
848,368
 
United States Settlement
  
 
46,789
 
  
 
54,747
 
Deferred revenue
  
 
19,029
 
  
 
21,027
 
Interest rate swap agreements
  
 
47,620
 
  
 
27,430
 
Accrued dividend
  
 
—  
 
  
 
17,910
 
Accrued interest
  
 
17,817
 
  
 
591
 
Accounts payable and other accrued liabilities
  
 
20,873
 
  
 
17,563
 
Other liabilities—disputed federal, state and local tax refunds
  
 
14,422
 
  
 
14,903
 
Deferred income taxes
  
 
30,394
 
  
 
30,394
 
    


  


Total liabilities
  
 
982,868
 
  
 
1,032,933
 
    


  


Commitments and contingencies
                 
Stockholders’ equity:
                 
Preferred stock, unissued
  
 
—  
 
  
 
—  
 
Common stock
  
 
18,402
 
  
 
18,402
 
Capital in excess of par value
  
 
105,315
 
  
 
122,468
 
Unearned compensation on restricted stock
  
 
(1,155
)
  
 
(1,000
)
Accumulated other comprehensive income (loss)
  
 
(10,232
)
  
 
36,174
 
Retained earnings (deficit)
  
 
(127,126
)
  
 
(134,088
)
    


  


    
 
(14,796
)
  
 
41,956
 
Treasury stock
  
 
(110,829
)
  
 
(133,030
)
    


  


Total stockholders’ equity (deficit)
  
 
(125,625
)
  
 
(91,074
)
    


  


Total liabilities and stockholders’ equity
  
$
857,243
 
  
$
941,859
 
    


  


 
See notes to condensed consolidated financial statements

3


Table of Contents
VENTAS, INC.
 
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
(In thousands, except per share amounts)
 
    
Three Months Ended
September 30,

  
Nine Months Ended
September 30,

    
2002

    
2001

  
2002

    
2001

Revenues:
                               
Rental income
  
$
47,650
 
  
$
46,063
  
$
140,903
 
  
$
137,242
Interest and other income
  
 
237
 
  
 
939
  
 
952
 
  
 
3,507
Gain on sale of Kindred Common Stock
  
 
1,192
 
  
 
—  
  
 
5,014
 
  
 
—  
    


  

  


  

    
 
49,079
 
  
 
47,002
  
 
146,869
 
  
 
140,749
    


  

  


  

Expenses:
                               
General and administrative
  
 
2,410
 
  
 
2,598
  
 
7,322
 
  
 
7,740
Professional fees
  
 
900
 
  
 
699
  
 
2,401
 
  
 
3,595
Amortization of restricted stock grants
  
 
354
 
  
 
444
  
 
1,491
 
  
 
1,286
Depreciation
  
 
10,414
 
  
 
10,447
  
 
31,233
 
  
 
31,326
Net loss on swap breakage
  
 
—  
 
  
 
—  
  
 
5,407
 
  
 
—  
Swap ineffectiveness
  
 
118
 
  
 
—  
  
 
298
 
  
 
—  
Interest
  
 
18,659
 
  
 
21,886
  
 
57,363
 
  
 
64,540
Interest on United States Settlement
  
 
1,331
 
  
 
1,605
  
 
4,204
 
  
 
3,053
    


  

  


  

Total expenses
  
 
34,186
 
  
 
37,679
  
 
109,719
 
  
 
111,540
    


  

  


  

Income before income taxes, discontinued operations and extraordinary loss
  
 
14,893
 
  
 
9,323
  
 
37,150
 
  
 
29,209
Provision (benefit) for income taxes
  
 
(2,200
)
  
 
469
  
 
(2,200
)
  
 
2,322
    


  

  


  

Income before discontinued operations and extraordinary loss
  
 
17,093
 
  
 
8,854
  
 
39,350
 
  
 
26,887
Discontinued operations (including gain on sale of assets)
  
 
—  
 
  
 
303
  
 
23,831
 
  
 
954
    


  

  


  

Income before extraordinary loss
  
 
17,093
 
  
 
9,157
  
 
63,181
 
  
 
27,841
Extraordinary loss on extinguishment of debt
  
 
—  
 
  
 
—  
  
 
(6,919
)
  
 
—  
    


  

  


  

Net income
  
$
17,093
 
  
$
9,157
  
$
56,262
 
  
$
27,841
    


  

  


  

Earnings Per Share:
                               
Basic:
                               
Income before discontinued operations and extraordinary loss
  
$
0.25
 
  
$
0.13
  
$
0.57
 
  
$
0.40
    


  

  


  

Net income
  
$
0.25
 
  
$
0.13
  
$
0.82
 
  
$
0.41
    


  

  


  

Diluted:
                               
Income before discontinued operations and extraordinary loss
  
$
0.24
 
  
$
0.13
  
$
0.56
 
  
$
0.39
    


  

  


  

Net income
  
$
0.24
 
  
$
0.13
  
$
0.80
 
  
$
0.40
    


  

  


  

Shares used in computing earnings per common share:
                               
Basic
  
 
69,098
 
  
 
68,491
  
 
68,895
 
  
 
68,375
Diluted
  
 
70,047
 
  
 
69,584